Sporadic venous malformations are genetic conditions primarily caused by somatic gain-of-function mutation of pIK3CA or TEK,an endothelial transmembrane receptor signaling through *** malformations are associated with...
详细信息
Sporadic venous malformations are genetic conditions primarily caused by somatic gain-of-function mutation of pIK3CA or TEK,an endothelial transmembrane receptor signaling through *** malformations are associated with pain,bleedings,thrombosis,pulmonary embolism,esthetic deformities and,in severe cases,life-threatening *** authorized medical treatment exists for patients with venous ***,we created a genetic mouse model of pIK3CA-related capillary venous malformations that replicates patient *** showed that these malformations only partially signal through AKT *** compared the efficacy of different drugs,including rapamycin,a mTORC1 inhibitor,miransertib,an AKT inhibitor and alpelisib,a pI3Kαinhibitor at improving the lesions seen in the mouse *** demonstrated the effectiveness of alpelisib in preventing vascular malformations’occurrence,improving the already established ones,and prolonging *** these findings,we were authorized to treat 25 patients with alpelisib,including 7 children displaying pIK3CA(n=16)or TEK(n=9)-related capillary venous malformations resistant to usual therapies including sirolimus,debulking surgical procedures or percutaneous *** assessed the volume of vascular malformations using magnetic resonance imaging(MRI)for each *** demonstrated improvement in all 25 *** malformations previously considered intractable were reduced and clinical symptoms were *** showed a decrease of 33.4%and 27.8%in the median volume of pIK3CA and TEK malformations respectively,over 6 months on *** conclusion,this study supports pI3Kαinhibition as a promising therapeutic strategy in patients with pIK3CA or TEK-related capillary venous malformations.
暂无评论